Hrt Financial LP Generation Bio Co. Transaction History

Hrt Financial LP

  • $15.6 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$4.68 - $8.34 $494,390 - $881,029
-105,639 Reduced 68.03%
49,644 $263,000
Q2 2022

Aug 12, 2022
BUY
$4.87 - $9.41 $471,586 - $911,217
96,835 Added 165.68%
155,283 $1.02 Million
Q1 2022

May 16, 2022
SELL
$4.16 - $7.76 $33,716 - $62,894
-8,105 Reduced 12.18%
58,448 $429,000
Q4 2021

Feb 14, 2022
BUY
$5.99 - $24.97 $398,652 - $1.66 Million
66,553 New
66,553 $471,000

Others Institutions Holding GBIO

# of Institutions
79
Shares Held
49.5M
Call Options Held
20.3K
Put Options Held
0
View Full List

About Generation Bio Co.

GBIO Quotes by TradingView
  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $166M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email